AU2981395A - Method of identifying and producing antigen peptides and use thereof as vaccines - Google Patents

Method of identifying and producing antigen peptides and use thereof as vaccines

Info

Publication number
AU2981395A
AU2981395A AU29813/95A AU2981395A AU2981395A AU 2981395 A AU2981395 A AU 2981395A AU 29813/95 A AU29813/95 A AU 29813/95A AU 2981395 A AU2981395 A AU 2981395A AU 2981395 A AU2981395 A AU 2981395A
Authority
AU
Australia
Prior art keywords
vaccines
identifying
antigen peptides
producing antigen
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29813/95A
Inventor
Klaus Eichmann
Bernhard Maier
Gabriele Niedermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2981395A publication Critical patent/AU2981395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
AU29813/95A 1994-07-04 1995-07-04 Method of identifying and producing antigen peptides and use thereof as vaccines Abandoned AU2981395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4423392A DE4423392A1 (en) 1994-07-04 1994-07-04 Methods of identifying antigenic peptides
DE4423392 1994-07-04
PCT/EP1995/002593 WO1996001429A1 (en) 1994-07-04 1995-07-04 Method of identifying and producing antigen peptides and use thereof as vaccines

Publications (1)

Publication Number Publication Date
AU2981395A true AU2981395A (en) 1996-01-25

Family

ID=6522207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29813/95A Abandoned AU2981395A (en) 1994-07-04 1995-07-04 Method of identifying and producing antigen peptides and use thereof as vaccines

Country Status (6)

Country Link
EP (1) EP0769147A1 (en)
JP (1) JPH10505665A (en)
AU (1) AU2981395A (en)
CA (1) CA2192565A1 (en)
DE (1) DE4423392A1 (en)
WO (1) WO1996001429A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1749597A (en) * 1996-01-19 1997-08-11 Virginia Mason Research Center Allele-specific peptide epitope strategy for vaccine development
US6994851B1 (en) 1997-07-10 2006-02-07 Mannkind Corporation Method of inducing a CTL response
US6977074B2 (en) 1997-07-10 2005-12-20 Mannkind Corporation Method of inducing a CTL response
CA2405363A1 (en) * 2000-04-28 2001-11-08 Ctl Immunotherapies Corp. Epitope synchronization in antigen presenting cells
US6861234B1 (en) 2000-04-28 2005-03-01 Mannkind Corporation Method of epitope discovery
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
CN101024842A (en) 2001-11-07 2007-08-29 曼康公司 Expression vectors encoding epitopes of target-associated antigens and its design method
WO2008100598A2 (en) 2007-02-15 2008-08-21 Mannkind Corporation A method for enhancing t cell response
US20110274723A1 (en) 2009-10-23 2011-11-10 Mannkind Corporation Cancer immunotherapy and method of treatment
KR101711458B1 (en) * 2015-03-06 2017-03-02 인하대학교 산학협력단 Polymer bound silica capillaries for separation of oligosaccharides or peptides and manufacturing method thereof
US20220193211A1 (en) * 2019-04-18 2022-06-23 Intellistem Technologies Inc. Overexpression of immunoproteasome in host cells for generating antigen-presenting cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200320A (en) * 1987-12-07 1993-04-06 National Jewish Center For Immunology And Respiratory Medicine Method for identifying useful polypeptide vaccines
CA2095323A1 (en) * 1990-10-30 1992-05-01 Jonathan B. Rothbard Peptide binding assays with mhc antigens
DE4143467C2 (en) * 1991-05-17 1995-02-09 Max Planck Gesellschaft Peptide motif and its use

Also Published As

Publication number Publication date
CA2192565A1 (en) 1996-01-18
JPH10505665A (en) 1998-06-02
DE4423392A1 (en) 1996-01-11
WO1996001429A1 (en) 1996-01-18
EP0769147A1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
AU6095696A (en) Immunogenic peptides of prostate specific antigen
AU4913097A (en) Nucleic acid vaccines against rickettsial diseases and methods of use
AU7242994A (en) Model for testing immunogenicity of peptides
PL315914A1 (en) Haemopoesive protein as well as method of and materials for obtaining same
AU1914595A (en) Isolated antigenic oncogene peptide fragments and uses
AU3379193A (en) Antigen binding proteins and methods for their production
AU1597795A (en) Method of enhancing the human immune system
EP0851765A4 (en) Therapeutic and prophylactic methods using heat shock proteins
AU2636097A (en) Method of producing amines and aminonitriles
EP0693931A4 (en) Immunogenic cancer proteins and peptides and method of use
PL314640A1 (en) Method of vaccinating against coccodiosis
AU2582195A (en) Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
HUP0000318A3 (en) Tumor vaccine and process for the preparation thereof
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU6976596A (en) Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof
AU5874798A (en) Vaccination methods and molecules
AU3919995A (en) Process and device for the preparation of medical-quality air
AU4013495A (en) Chemokine-like proteins and methods of use
GB9516293D0 (en) Novel peptides and their use as vaccines
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
EP0414574A3 (en) Tertiary amino alcohol and method of producing the same
AU7044194A (en) Preparation of microparticles and method of immunization
AU3709495A (en) Nucleic acid preparation for immunization and method for immunization using the same
AU2517995A (en) Immunogenic carcinoembryonic antigen and methods of use and production